C
Castle Biosciences D
D
CSTL
20.250
USD
0.49
(2.48%)
مغلق
حجم التداول
13,369
الربح لكل سهم
-2
العائد الربحي
-
P/E
33
حجم السوق
577,410,707
العنوان: Castle Biosciences
القطاع: Healthcare
الصناعة: Diagnostics & Research
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.